NovoCure Limited (NVCR)
NASDAQ: NVCR
· Real-Time Price · USD
11.73
0.14 (1.21%)
At close: Aug 15, 2025, 3:59 PM
11.79
0.51%
After-hours: Aug 15, 2025, 05:59 PM EDT
NovoCure Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 630.16M | 621.71M | 605.22M | 577.74M | 549.96M | 525.66M | 509.34M | 503.98M | 507.66M | 522.48M | 537.84M | 542.62M | 545.23M | 537.88M | 535.03M | 545.77M | 544.83M | 527.23M |
Cost of Revenue | 148.83M | 142.01M | 137.18M | 136.27M | 132.99M | 132.35M | 128.28M | 124.61M | 122.27M | 116.75M | 114.87M | 115.67M | 116.12M | 116.22M | 114.88M | 113.33M | 111.52M | 108.39M |
Gross Profit | 481.33M | 479.7M | 468.04M | 441.47M | 416.97M | 393.3M | 381.06M | 379.37M | 385.39M | 405.72M | 422.97M | 426.96M | 429.11M | 421.66M | 420.15M | 432.44M | 433.31M | 418.84M |
Operating Income | -172.78M | -166.87M | -170.52M | -158.94M | -185.09M | -214.14M | -232.87M | -224.13M | -190.5M | -148.97M | -89.52M | -69.94M | -53.88M | -45.05M | -44.33M | -8.84M | 14.73M | 33.69M |
Interest Income | n/a | n/a | n/a | 13.18M | 23.2M | 31.96M | 41.13M | 38.37M | 29.54M | 20.78M | 11.61M | 1.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -142.06M | -129.81M | -131.16M | -114.49M | -141.13M | -172.3M | -191.74M | -185.76M | -160.96M | -130.41M | -81.85M | -74.86M | -61.98M | -51.86M | -52.08M | -17.68M | 3.9M | 21.18M |
Net Income | -170.95M | -164.19M | -168.63M | -149.78M | -168.7M | -192.74M | -207.04M | -197.27M | -174.36M | -140.95M | -92.53M | -81.69M | -68.24M | -58.87M | -58.35M | -26.98M | -4.57M | 11.73M |
Selling & General & Admin | 441.41M | 434.74M | 428.92M | 387.66M | 387.58M | 392.49M | 390.87M | 379.93M | 353.98M | 331.13M | 306.41M | 288.7M | 278.61M | 269.09M | 263.18M | 252.91M | 245.53M | 232.5M |
Research & Development | 212.7M | 211.82M | 209.65M | 212.74M | 214.48M | 214.96M | 223.06M | 223.57M | 221.91M | 223.56M | 206.09M | 208.2M | 204.38M | 197.62M | 201.3M | 188.37M | 173.05M | 152.65M |
Other Expenses | n/a | -27K | -27K | -27K | -27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 654.11M | 646.57M | 638.56M | 600.4M | 602.06M | 607.45M | 613.93M | 603.5M | 575.89M | 554.69M | 512.5M | 496.9M | 482.99M | 466.71M | 464.49M | 441.29M | 418.58M | 385.15M |
Interest Expense | n/a | n/a | n/a | 9.17M | 9.17M | 9.17M | 9.17M | 13.94M | 15.14M | 15.14M | 15.14M | 1.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 240.1M | 239.65M | 239.06M | 230.84M | 228.97M | 230.85M | 226.81M | 217.25M | 200.68M | 186.94M | 173.66M | 163.01M | 154.2M | 143.58M | 137.06M | 129.43M | 126.22M | 120.54M |
Cost & Expenses | 802.94M | 788.58M | 775.74M | 736.67M | 735.05M | 739.8M | 742.21M | 728.12M | 698.16M | 671.44M | 627.36M | 612.57M | 599.12M | 582.93M | 579.36M | 554.61M | 530.09M | 493.54M |
Income Tax Expense | 28.89M | 34.37M | 37.47M | 35.29M | 27.57M | 20.44M | 15.3M | 11.5M | 13.4M | 10.54M | 10.69M | 6.83M | 6.26M | 7.01M | 6.28M | 9.3M | 8.46M | 9.45M |
Shares Outstanding (Basic) | 111.57M | 110.28M | 107.83M | 108.25M | 107.7M | 107.27M | 106.98M | 106.77M | 106.29M | 105.67M | 105.03M | 104.88M | 104.63M | 104.19M | 103.88M | 100.95M | 103.48M | 102.63M |
Shares Outstanding (Diluted) | 111.57M | 110.28M | 107.83M | 108.25M | 107.7M | 107.27M | 106.98M | 106.77M | 106.29M | 105.67M | 105.03M | 104.88M | 104.63M | 104.19M | 103.88M | 103.73M | 103.48M | 102.63M |
EPS (Basic) | -1.56 | -1.51 | -1.56 | -1.39 | -1.57 | -1.8 | -1.94 | -1.86 | -1.65 | -1.34 | -0.88 | -0.77 | -0.65 | -0.56 | -0.56 | -0.26 | -0.04 | 0.12 |
EPS (Diluted) | -1.56 | -1.51 | -1.56 | -1.39 | -1.57 | -1.8 | -1.94 | -1.86 | -1.65 | -1.34 | -0.88 | -0.77 | -0.65 | -0.56 | -0.56 | -0.27 | -0.05 | 0.11 |
EBITDA | -110.77M | -105.45M | -107.58M | -132.87M | -158.68M | -187.87M | -208.72M | -202.77M | -169.28M | -127.81M | -68.48M | -59.35M | -43.22M | -34.56M | -34.08M | 1.21M | 24.24M | 43.33M |
EBIT | -123.11M | -117.16M | -120.82M | -145.73M | -171.88M | -200.96M | -219.69M | -213.71M | -180.08M | -138.55M | -79.1M | -69.94M | -53.88M | -45.05M | -44.33M | -8M | 15.58M | 34.54M |
Depreciation & Amortization | 12.33M | 11.74M | 11.23M | 10.85M | 11.2M | 11.06M | 10.97M | 10.95M | 10.8M | 10.73M | 10.62M | 10.59M | 10.66M | 10.49M | 10.25M | 10.06M | 9.51M | 9.63M |